Results 31 to 40 of about 196,582 (195)

Loss of Hepatic Mitochondrial Long-Chain Fatty Acid Oxidation Confers Resistance to Diet-Induced Obesity and Glucose Intolerance

open access: yesCell Reports, 2017
The liver has a large capacity for mitochondrial fatty acid β-oxidation, which is critical for systemic metabolic adaptations such as gluconeogenesis and ketogenesis.
Jieun Lee   +7 more
doaj   +1 more source

Metabolic switch from glycogen to lipid in the liver maintains glucose homeostasis in neonatal mice

open access: yesJournal of Lipid Research, 2023
Neonates strive to acquire energy when the continuous transplacental nutrient supply ceases at birth, whereas milk consumption takes hours to start.
Liangkui Li   +11 more
doaj   +1 more source

Structural snapshots of Mycobacterium tuberculosis enolase reveal dual mode of 2PG binding and its implication in enzyme catalysis

open access: yesIUCrJ, 2023
Enolase, a ubiquitous enzyme, catalyzes the reversible conversion of 2-phosphoglycerate (2PG) to phosphoenolpyruvate (PEP) in the glycolytic pathway of organisms of all three domains of life. The underlying mechanism of the 2PG to PEP conversion has been
Mohammed Ahmad   +11 more
doaj   +1 more source

Unraveling the Regulation of Hepatic Gluconeogenesis [PDF]

open access: yes, 2019
Hepatic gluconeogenesis, de novo glucose synthesis from available precursors, plays a crucial role in maintaining glucose homeostasis to meet energy demands during prolonged starvation in animals.
Zhiguang Su   +3 more
core   +1 more source

Leupaxin promotes hepatic gluconeogenesis and glucose metabolism by coactivation with hepatic nuclear factor 4α

open access: yesMolecular Metabolism
Background: As the primary source of glucose during fasting, hepatic gluconeogenesis is rigorously regulated to maintain euglycemia. Abnormal gluconeogenesis in the liver can lead to hyperglycemia, a key diagnostic marker and the primary pathological ...
Xiaomin Luo   +9 more
doaj   +1 more source

Lactate-Induced Glucose Output Is Unchanged by Metformin at a Therapeutic Concentration – A Mass Spectrometry Imaging Study of the Perfused Rat Liver

open access: yesFrontiers in Pharmacology, 2018
Metformin is the first line drug for type 2 diabetes but its molecular mechanisms remain unclear. Here, we have studied the acute effect of a therapeutically relevant intrahepatic concentration of metformin on glucose production from lactate. We selected
Giulio Calza   +11 more
doaj   +1 more source

Glycolysis/gluconeogenesis—non-mitochondrial version.

open access: yes, 2022
Glycolysis/gluconeogenesis—non-mitochondrial version.
Morten Beck Rye (14009114)   +3 more
core   +1 more source

Serotonergic Control of Metabolic Homeostasis

open access: yesFrontiers in Cellular Neuroscience, 2017
New treatments are urgently needed to address the current epidemic of obesity and diabetes. Recent studies have highlighted multiple pathways whereby serotonin (5-HT) modulates energy homeostasis, leading to a renewed interest in the identification of 5 ...
Steven C. Wyler   +6 more
doaj   +1 more source

Vitamin B2 enables regulation of fasting glucose availability

open access: yeseLife, 2023
Flavin adenine dinucleotide (FAD) interacts with flavoproteins to mediate oxidation-reduction reactions required for cellular energy demands. Not surprisingly, mutations that alter FAD binding to flavoproteins cause rare inborn errors of metabolism (IEMs)
Peter M Masschelin   +20 more
doaj   +1 more source

AMPK inhibits liver gluconeogenesis: fact or fiction?

open access: yes, 2023
Is there a role for AMPK in the control of hepatic gluconeogenesis and could targeting AMPK in liver be a viable strategy for treating type 2 diabetes? These are frequently asked questions this review tries to answer.
Hue, Louis   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy